(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
Currently, Cincinnati Children’s is conducting many research studies that could change the face of diagnosis and care for HLH. We have six physician scientists who are focused solely on basic and translational research in HLH. Some of our ongoing innovative work includes:
While we already have strong collaborations with the National Institutes of Health (NIH) and other HLH centers in China, Japan, Vietnam, Canada and Sweden, we plan to further extend our scientific collaborations across Europe, Central and South America, and Asia.
We are also working to increase research funding for HLH through industry grants, additional NIH funding and philanthropic support.
> Read some of our HLH research articles from PubMed.gov
HLH Meets its Match: Dr. Lisa Filipovich has spent her career unraveling the mysteries of the childhood immune disorder hemophagocytic lymphohistiocytosis (HLH). Her focus now is to improve treatment and ultimately prevent the disease.
Calming a Storm in the Immune System: Dr. Michael Jordan developed the perforin-deficient animal model that is helping advance the study of better treatments for HLH. He is now leading a multicenter clinical trial testing a new approach for treating HLH.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.